Corrigendum to ‘212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models’ [Nucl Med Biol 58 (2018) 67–73]

The authors regret that a funding source was not acknowledged in the original paper. The correct Financial Support statement can be seen below.

Source: Nuclear Medicine and Biology - April 25, 2018 Category: Nuclear Medicine Authors: Benjamin B. Kasten, Abhishek Gangrade, Harrison Kim, Jinda Fan, Soldano Ferrone, Cristina R. Ferrone, Kurt R. Zinn, Donald J. Buchsbaum Tags: Corrigendum Source Type: research